Compare SMTI & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMTI | LWAY |
|---|---|---|
| Founded | 1982 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 313.5M | 481.4M |
| IPO Year | 2008 | 1995 |
| Metric | SMTI | LWAY |
|---|---|---|
| Price | $34.29 | $29.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $34.00 | ★ $34.50 |
| AVG Volume (30 Days) | ★ 313.8K | 98.3K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 48.33 |
| EPS | 0.05 | ★ 0.30 |
| Revenue | $15,586,976.00 | ★ $103,350,000.00 |
| Revenue This Year | $17.31 | $16.64 |
| Revenue Next Year | $12.48 | $17.28 |
| P/E Ratio | $685.00 | ★ $100.22 |
| Revenue Growth | ★ 32.47 | N/A |
| 52 Week Low | $16.05 | $17.31 |
| 52 Week High | $35.70 | $34.20 |
| Indicator | SMTI | LWAY |
|---|---|---|
| Relative Strength Index (RSI) | 82.95 | 48.67 |
| Support Level | $20.47 | $28.75 |
| Resistance Level | $34.33 | $31.23 |
| Average True Range (ATR) | 0.85 | 1.12 |
| MACD | 0.37 | -0.20 |
| Stochastic Oscillator | 99.05 | 27.61 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.